-
1
-
-
0019979986
-
Causes of initial remission failure in acute myelogenous leukemia
-
Estey EH, Keating MJ, McCredie KB, Bodey G, Freireich E. Causes of initial remission failure in acute myelogenous leukemia. Blood 1982; 60: 309-315.
-
(1982)
Blood
, vol.60
, pp. 309-315
-
-
Estey, E.H.1
Keating, M.J.2
McCredie, K.B.3
Bodey, G.4
Freireich, E.5
-
2
-
-
0023711896
-
Cytogenetic pattern in acute myelogenous leukemia: A major reproducible determinant of outcome
-
Keating MJ, Smith T, Kantarjian H, Cork A, Walters R, Trujillo JM, McCredie KB, Gehan EA, Freireich EJ. Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome. Leukemia 1988; 2: 403-412.
-
(1988)
Leukemia
, vol.2
, pp. 403-412
-
-
Keating, M.J.1
Smith, T.2
Kantarjian, H.3
Cork, A.4
Walters, R.5
Trujillo, J.M.6
McCredie, K.B.7
Gehan, E.A.8
Freireich, E.J.9
-
3
-
-
0019812609
-
Treatment of acute myelocytic leukemia: A study by Cancer and Leukemia Group B
-
Rai KR, Holland JF, Glidewell OJ, Weinberg V, Brunner K, Obrecht JP, Preisler HD, Nawabi IW, Prager D, Carey RW, Cooper MR, Haurani F, Hutchinson JL, Silver RT, Falkson G, Wiernik P, Hoagland HC, Bloomfield CD, James GW, Gottlieb A, Ramanan SV, Blom J, Nissen NI, Bank A, Ellison RR, Kung F, Henry P, Mclntyre OR, Kaan SK. Treatment of acute myelocytic leukemia: a study by Cancer and Leukemia Group B. Blood 1981; 58: 1203-1212.
-
(1981)
Blood
, vol.58
, pp. 1203-1212
-
-
Rai, K.R.1
Holland, J.F.2
Glidewell, O.J.3
Weinberg, V.4
Brunner, K.5
Obrecht, J.P.6
Preisler, H.D.7
Nawabi, I.W.8
Prager, D.9
Carey, R.W.10
Cooper, M.R.11
Haurani, F.12
Hutchinson, J.L.13
Silver, R.T.14
Falkson, G.15
Wiernik, P.16
Hoagland, H.C.17
Bloomfield, C.D.18
James, G.W.19
Gottlieb, A.20
Ramanan, S.V.21
Blom, J.22
Nissen, N.I.23
Bank, A.24
Ellison, R.R.25
Kung, F.26
Henry, P.27
Mclntyre, O.R.28
Kaan, S.K.29
more..
-
4
-
-
0023126559
-
High dose cytosine arabinoside as the initial treatment of poor risk patients with acute nonlymphocytic leukemia: A leukemia intergroup study
-
Preisler HD, Raza A, Barcos M, Azarnia N, Larson R, Walker I, Browman M, Grunwald H, D'Arrigo P, Doeblin T, Bloom M, Stein A, Logue G, Goldberg J, Kirshner J, Gottlieb A, Bennett J. High dose cytosine arabinoside as the initial treatment of poor risk patients with acute nonlymphocytic leukemia: a leukemia intergroup study. J Clin Oncol 1987; 5: 75-82.
-
(1987)
J Clin Oncol
, vol.5
, pp. 75-82
-
-
Preisler, H.D.1
Raza, A.2
Barcos, M.3
Azarnia, N.4
Larson, R.5
Walker, I.6
Browman, M.7
Grunwald, H.8
D'Arrigo, P.9
Doeblin, T.10
Bloom, M.11
Stein, A.12
Logue, G.13
Goldberg, J.14
Kirshner, J.15
Gottlieb, A.16
Bennett, J.17
-
5
-
-
0347354671
-
Context and catalysts for change in health care markets
-
Lichiello P, Madden CW. Context and catalysts for change in health care markets. Health Aff 1996; 15; 121-129.
-
(1996)
Health Aff
, vol.15
, pp. 121-129
-
-
Lichiello, P.1
Madden, C.W.2
-
6
-
-
1542534596
-
Academic health centers in a changing environment
-
Blumenthal D, Meyer GS. Academic health centers in a changing environment. Health Aff 1996; 15: 200-215.
-
(1996)
Health Aff
, vol.15
, pp. 200-215
-
-
Blumenthal, D.1
Meyer, G.S.2
-
7
-
-
0031014450
-
Cancer statistics, 1997
-
Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. Cancer J Clin 1997; 47: 5-27.
-
(1997)
Cancer J Clin
, vol.47
, pp. 5-27
-
-
Parker, S.L.1
Tong, T.2
Bolden, S.3
Wingo, P.A.4
-
8
-
-
0031014449
-
Giving life to numbers
-
Cunningham MP. Giving life to numbers. CA J Clin 1997; 47: 3-4.
-
(1997)
CA J Clin
, vol.47
, pp. 3-4
-
-
Cunningham, M.P.1
-
9
-
-
0021320165
-
Importance of prognostic factors in cancer clinical trials
-
Simon R. Importance of prognostic factors in cancer clinical trials. Cancer Treat Rep 1984; 68: 185-192.
-
(1984)
Cancer Treat Rep
, vol.68
, pp. 185-192
-
-
Simon, R.1
-
10
-
-
0028223112
-
Generalizing the results of randomized clinical trials
-
Bailey KR. Generalizing the results of randomized clinical trials. Controlled Trials 1994; 15: 15-23.
-
(1994)
Controlled Trials
, vol.15
, pp. 15-23
-
-
Bailey, K.R.1
|